Retrospective Study
Copyright ©The Author(s) 2016.
World J Surg Proced. Jul 28, 2016; 6(2): 19-29
Published online Jul 28, 2016. doi: 10.5412/wjsp.v6.i2.19
Table 5 Unadjusted intraoperative/postoperative outcomes among the unmatched population cohort
CharacteristicSurgery only n = 3593 (94.21%)Chemotherapy n = 64 (1.68%)Radiotherapy n = 100 (2.62%)Chemo and radio n = 57 (1.49%)P-value1
30-d mortality (%)83 (2.31)3 (4.69)9 (9.00)5 (8.77)< 0.0012
Overall morbidity (%)415 (11.55)13 (20.31)21 (21.00)17 (29.82)< 0.0012
Wound infection3 (0.08)0 (0.00)0 (0.00)0 (0.00)--
Pneumonia4 (0.11)0 (0.00)0 (0.00)0 (0.00)--
Urinary tract infection1 (0.03)0 (0.00)0 (0.00)0 (0.00)--
Return to OR170 (4.73)7 (10.94)10 (10.00)4 (7.02)0.0122
Venous thromboembolism70 (1.95)0 (0.00)2 (2.00)3 (5.26)0.212
Cardiac complication47 (1.31)2 (3.13)2 (2.00)4 (7.02)0.0022
Shock/sepsis92 (2.62)2 (3.13)5 (5.00)2 (3.51)0.513
Unplanned intubation169 (4.70)5 (7.81)12 (12.00)7 (12.28)< 0.0012
Bleeding transfusion133 (3.70)8 (12.50)7 (7.00)10 (17.54)< 0.0012
Renal complication22 (0.61)0 (0.00)0 (0.00)0 (0.00)--
On ventilator > 48 h2 (0.06)1 (1.56)0 (0.00)0 (0.00)--
Organ space SSI38 (1.06)0 (0.00)1 (1.00)0 (0.00)--
Serious morbidity (%)372 (10.35)12 (18.75)19 (19.00)10 (17.54)0.0022
Length of stay (d), median (IQR)6 (4-8)5 (4-7)6 (5-9)5 (4-8)0.134
Prolonged length of stay (%)899 (25.02)10 (15.63)28 (28.00)13 (22.81)0.306
Operative time (min), median (IQR)160 (121-214)187 (140-246)202 (151-253)182 (142-249)< 0.0012
Prolonged operative time (%)858 (23.44)23 (35.94)41 (41.00)20 (35.09)< 0.0012